New registry aims to find best blood thinner combo for rare clotting disorder

NCT ID NCT05646394

Recruiting now Disease control Sponsor: McMaster University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study collects information from 150 adults with antiphospholipid syndrome who had an artery clot in the past year. Participants are already on one of four blood-thinning treatments. Researchers will track who has another clot or a major bleed over two years to see which treatment works best and is safest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

antiphospholipid syndrome arterial occlusion Hemorrhage myocardial infarction stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANTIPHOSPHOLIPID SYNDROME ARTERIAL THROMBOSIS

Contacts and locations

Locations

Clinica Universitaria Reina Fabiola
RECRUITING

Córdoba, Argentina
Instituto de Investigaciones en Salud Pública, Universidad de Buenos Aires
RECRUITING

Buenos Aires, Buenos Aires F.D., C1113 AAJ, Argentina
McMaster University
RECRUITING

Hamilton, Ontario, L9H 7M1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.